Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations
Launched by UNIVERSITY HOSPITAL ERLANGEN · Nov 16, 2020
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a confirmed venous malformation of the upper/lower extremity independent of previous therapy with epi- and/or subfascial localization of the venous malformation independent of the local extent (cross-articular or not)
- • Compression stocking can be put on independently or by the parents
- • Written declaration of consent present
- Exclusion Criteria:
- • Lack of compliance, patient is not available for control appointments
- • Additional drug therapy (anticoagulation) for extensive venous malformations with threatening thromboembolic complications
- • Known allergic reaction/intolerance to components of flat-knitted compression stockings
- • Pregnancy
- • Rejection of the study participation by the patient
- • Contraindications for the planned MRI examination (pacemakers, implants not suitable for MRI, claustrophobia)
- • Occurrence of an emergency situation
- • Severe heart failure as contraindication for compression therapy
- • Peripheral arterial disease as contraindication for compression therapy
About University Hospital Erlangen
University Hospital Erlangen is a leading academic medical center affiliated with Friedrich-Alexander University, dedicated to advancing healthcare through innovative research, education, and clinical excellence. Renowned for its multidisciplinary approach, the institution specializes in a wide array of medical fields, including oncology, neurology, and cardiology. With a commitment to patient-centered care, University Hospital Erlangen actively engages in clinical trials to explore new therapies and improve treatment outcomes, fostering collaboration between researchers, healthcare professionals, and patients. Through its state-of-the-art facilities and cutting-edge research initiatives, the hospital plays a pivotal role in shaping the future of medicine both nationally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erlangen, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials